Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Nemera
Nemera
Activities:
Drug Delivery
Medical Devices
Pharmaceutical
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
Therapeutic: ensifentrine for chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) comes in various guises, including chronic bronchitis and emphysema; and, although incurable, the symptoms can be managed with...
Merck’s clesrovimab meets all primary endpoints in Phase IIb/III trial for RSV in infants
A teaser of the Phase IIb/III trial released by Merck indicates that clesrovimab can reduce the need to medically attend lower respiratory infections caused by RSV in infants
Bringing biotech to the Baltics: the rise of Lithuania
Lithuania’s biotechnology competencies lie in cell and gene therapies, enzymes and the wider pharmaceutical industry, offering companies a rich pool of talent in a...
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Drug Delivery
Cristalia products with Nemera’s reusable pen injector commercialised in Brazil
Cristalia’s human growth hormone will be administered with CRISPEN, a pen injector designed by Nemera
Manufacturing
Nemera extends manufacturing capabilities in North America
With a newly acquired space in Vernon Hills, Nemera has opened a third location in the US, in addition to the manufacturing facility in Buffalo Grove and Innovation Center in Chicago
Manufacturing
Nemera's manufacturing facility inaugurated in Poland
The total area of the new site covers over 11,000 square metres including a 3,400 square metres clean room space
Finance
Nemera to build drug delivery device facility in Poland
The production plant is being built on an area of 5 hectares with dedicated expandable clean room space
Regulatory
Nemera updates branding and website
“We are thrilled to launch our new identity that re-unites our purpose of putting patients first and our commitment of being a holistic and agile partner”
Manufacturing
BIOMM to commercialise Nemera's reusable insulin pen
BIOMM will market the product under the trade name Lifepen in Brazil, where around 16.8 million people suffer from diabetes
Finance
Nemera to acquire Copernicus
The acquisition establishes Nemera’s operations footprint in Eastern Europe.
Subscribe now